{"id":3566,"date":"2026-03-13T15:43:00","date_gmt":"2026-03-13T15:43:00","guid":{"rendered":"https:\/\/www.thermofisher.com\/blog\/connectedlab\/?p=3566"},"modified":"2026-03-13T15:43:02","modified_gmt":"2026-03-13T15:43:02","slug":"watson-lims-7-7-2-upgrade","status":"publish","type":"post","link":"https:\/\/www.thermofisher.com\/blog\/connectedlab\/watson-lims-7-7-2-upgrade\/","title":{"rendered":"Upgrading to Watson\u2122 LIMS\u00a0version\u00a07.7.2: Strengthening\u00a0compliance,\u00a0pharmacokinetic\u00a0analytics\u00a0and\u00a0immunogenicity\u00a0workflows\u00a0"},"content":{"rendered":"\n
\n

Article Summary<\/h2>\n\n\n\n

In bioanalysis, the pressure rarely comes from one direction. Regulatory expectations are tightening. Study designs are growing more adaptive and complex. Immunogenicity strategies demand deeper statistical scrutiny. Sponsors expect faster turnaround with greater transparency. And audit readiness is no longer an event on the calendar\u2014it is a continuous state of operational discipline.<\/p>\n\n\n\n

If you are already running Thermo Scientific\u2122 Watson\u2122 LIMS Software<\/a>, you have built your workflows on a platform purpose-built for bioanalysis\u2014trusted by thousands of users worldwide and embedded across leading pharma and CRO environments.\u00b9 That foundation matters. It is why Watson LIMS has remained the gold standard in regulated bioanalytical<\/a> laboratories for over two decades.<\/p>\n\n\n\n

But the question for established users today is not whether Watson LIMS is the right system. The question is whether your current version is fully enabling the next phase of performance your lab now demands.<\/p>\n<\/div>\n\n\n\n

\"\"<\/figure>\n\n\n\n

What challenges are bioanalytical laboratories facing today?<\/h2>\n\n\n\n

Watson LIMS version 7.7.2 is not a routine update. It is a strategic evolution\u2014combining stronger security, enhanced compliance infrastructure, and advanced analytics integration to help existing customers modernize with confidence, without disrupting validated processes. \u00b2<\/p>\n\n\n\n

Most long-standing Watson LIMS users have spent years refining their processes. Study design governance, chain of custody control, regression workflows, immunogenicity analysis, reporting discipline\u2014these are not theoretical capabilities. They are embedded operational muscle.<\/p>\n\n\n\n

Yet as laboratories scale, subtle inefficiencies emerge:<\/p>\n\n\n\n